Amendment and Mail Process Complete

S

Mallinckrodt Pharmaceuticals Ireland Limited

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88464898 FILING DATE 06/07/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY LINDEMYER, ANKHI MUKHE
L.O. ASSIGNED N50-NOT FOUND

PUB INFORMATION

RUN DATE 02/25/2020
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 02/24/2020
LITERAL MARK ELEMENT S

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) NO 1 (b) NO 1 (b) NO
44D YES 44D NO 44D NO
44E NO 44E YES 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT S
MARK DRAWING CODE 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG YES

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Mallinckrodt Pharmaceuticals Ireland Limited
ADDRESS College Business & Technology Park
Cruiserath Road, Blanchardstown
Dublin 15, D15TX2V
ENTITY 99-Private Company Limited by Shares
CITIZENSHIP Ireland

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; medical gases for inhalation; bioengineered tissues for surgical implantation
INTERNATIONAL CLASS 010
          DESCRIPTION TEXT Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; Therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; injection devices incorporating prefilled syringes containing injectable pharmaceuticals for manual injection
INTERNATIONAL CLASS 040
          DESCRIPTION TEXT Custom manufacturing of pharmaceuticals and active pharmaceutical ingredients
INTERNATIONAL CLASS 041
          DESCRIPTION TEXT Educational services, namely, training in the fields of pharmaceutical dosing and training in the use and operation of medical devices used to administer nitric oxide to a patient and medical devices used to administer extracorporeal photopheresis to a patient; educational services, namely, providing classes, seminars, and workshops in the fields of pharmaceuticals and medical devices
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Scientific research services for medical purposes

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 010 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 040 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 041 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
COLORS CLAIMED STATEMENT The color(s) blue and purple is/are claimed as a feature of the mark.
DESCRIPTION OF MARK The mark consists of a design of a stylized "S" in purple, with a design of 5 vertical lines that vary in length across the middle of the "S", with the tallest in the middle and the shortest on the outside, in blue and purple fading from top to bottom.


FOREIGN INFORMATION
PRIORITY CLAIMED SEC. 44(D) ON Ireland
APPLICATION NO. 2019/01023
APPLICATION FILING DATE 06/05/2019
FOREIGN REG NO. 261387
FOREIGN REG DATE 06/05/2019
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION 06/04/2029
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
02/24/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 011
02/24/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 010
02/20/2020 ALIE A ASSIGNED TO LIE 009
02/13/2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 008
08/26/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 007
08/26/2019 GNRT F NON-FINAL ACTION E-MAILED 006
08/26/2019 CNRT R NON-FINAL ACTION WRITTEN 005
08/24/2019 DOCK D ASSIGNED TO EXAMINER 004
06/22/2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED 003
06/21/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
06/11/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Jeannine A Rittenhouse
CORRESPONDENCE ADDRESS Jeannine A Rittenhouse
IPHORGAN LTD.
195 ARLINGTON HEIGHTS ROAD, SUITE 125
BUFFALO GROVE, IL 60089
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed